AE-941 in Treating Patients With Relapsed or Refractory Multiple Myeloma

NCT00022282 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

AEterna Zentaris